News

Lic;ensing/Collab opportunity: therapeutic to treat retinal inflammation and neurodegeneration

Opportunity for Therapeutic to Treat Retinal Inflammation and Neurodegeneration

Currently, there is no effective treatment for many types of retinal degeneration. Nor are there sufficient treatments for autoimmune uveitis, as current uveitis treatment primarily uses steroidal anti-inflammatory medication, which can produce significant unwanted side effects with long-term use
More
blank new placeholder image

OTT Signs Partnership Intermediary Agreement with BioHealth Innovation – Entrepreneur In Residence Program Planned

The NIH Office of Technology Transfer (OTT) has signed a new Partnership Intermediary Agreement (PIA) with BioHealth Innovation (BHI), a new regional private-public partnership in Maryland focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding
More
blank new placeholder image

NIH OTT FY-2011 Annual Report Now Available

The OTT is pleased to announce that the annual report for Fiscal Year 2011 is now available for downloading. Click the icon below to download and view the report.
More
blank new placeholder image

OTT’s Samuel E. Bish, Ph.D. Selected as the 2011 Technology Transfer “Rookie of the Year” by the Federal Laboratory Consortium Mid-Atlantic Region

The Federal Laboratory Consortium for Technology Transfer Mid-Atlantic Region (FLC-MAR) has selected Samuel E. Bish, Ph.D., a Licensing & Patenting Manager in the Cancer Branch of the NIH Office of Technology Transfer (OTT), as the 2011 winner of its Rookie of the Year Award. The FLC-MAR Rookie of
More